Primary sources

FDA and state board links, in one place.

Start with federal compounding pages, then the pharmacy boards for states you practice or ship into. Vendor PDFs are not a substitute. Verify pages still match what you cite.

← Provider resources·Status bands·How to read these pages

Federal

FDA Section 503A Bulk Drug Substances ListsFederal
FDA
The starting map for whether a bulk peptide can even be nominated or listed for patient-specific compounding.
503A · Category 1 · PCAC · compound eligibility
FDA Human Drug Compounding OverviewFederal
FDA
Defines the federal compounding frame clinics and pharmacies argue inside.
503A · 503B · essentially a copy · office use
Bulk substances that may present significant safety risksFederal
FDA
Names substances FDA associates with compounding safety concerns. Read the current page before building a menu.
BPC-157 · TB-500 · safety risks · immunogenicity
FDA concerns with unapproved GLP-1 drugs used for weight lossFederal
FDA
Explains why compounded GLP-1 programs need tighter intake and syringe counseling.
GLP-1 · semaglutide salts · dosing errors
FDA Drug Shortages DatabaseFederal
FDA
Shortage status changes what compounding pathways pharmacies will defend.
shortage list · essentially a copy · GLP-1
FDA Unapproved Drugs InitiativeFederal
FDA
Context for enforcement against products marketed for human use without approval.
enforcement · RUO · unapproved drugs

State boards and supervision

Expand per state on a rolling basis. NABP remains the master index when your footprint leaves this short list.

NABP State Board of Pharmacy LinksAll states
NABP
Fast path to the pharmacy board that actually licenses your compounding partner.
board contact · licensing
California Board of Pharmacy — CompoundingCA
California Board of Pharmacy
California clinics often hit out-of-state pharmacy and documentation rules first.
out-of-state pharmacy · patient-specific documentation
Texas State Board of PharmacyTX
Texas State Board of Pharmacy
Common jurisdiction for med-spa and telehealth peptide programs.
nonresident pharmacy · prescriber documentation
Florida Board of PharmacyFL
Florida Board of Pharmacy
Florida volume and nonresident pharmacy rules show up in pharmacy letters.
503B · nonresident · office use
Ohio Board of PharmacyOH
Ohio Board of Pharmacy
Useful example of state enforcement heat around compounded GLP-1s.
GLP-1 · med spa enforcement
Washington Pharmacy Quality Assurance CommissionWA
Washington PQA
State sterile compounding posture for Pacific Northwest programs.
sterile compounding · GLP-1
Federation of State Medical BoardsFederal reference
FSMB
Starting point for medical-board supervision questions that pharmacy boards do not answer.
medical director · supervision · med spa

Educational reference only. Not legal advice. PeptIQ does not sell or dispense peptides. For the interactive federal-plus-state matrix, signed-in clinics use Education → Legal Reference in the provider console.